Home > Boards > US Listed > Medical - Drugs > Cynapsus Therapeutics Inc. (CYNA)

TOB

Followed By 159
Posts 6072
Boards Moderated 1
Alias Born 09/15/2010

TOB

Sunday, June 01, 2014 12:17:44 PM

Re: None

Post# of 1014
Quote:
Investor misconceptions about Cynapsus have led to an incredible buying opportunity.

We believe the company's APL-130277 is a potential $700 million product.

Cynapsus recently raised $25 million in cash, enough to fund operations through the NDA filing.

Our DCF valuation pegs the shares at $2.25-2.50 right now, with upside to $4.50 on a take-out in 2016. Link to SA article

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y